Screener
Madrigal Pharmaceuticals, Inc. MDGL Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Trade receivables, net | 192,311 | 134,476 |
| Inventory | 99,391 | 74,841 |
| Prepaid expenses and other current assets | 68,570 | 47,804 |
| Total current assets | 1,199,180 | 1,245,770 |
| Property and equipment, net | 11,592 | 1,499 |
| Intangible assets, net | 7,187 | 7,381 |
| Operating lease right-of-use assets | 5,578 | 4,939 |
| Other noncurrent assets | 21,108 | — |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s total current assets?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported total current assets of $1.2B in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s total current assets increased by 19.5% year-over-year, from $1B to $1.2B.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s total current assets has grown at a 34.3% compound annual growth rate (CAGR), from $285.16M to $1.25B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude